Literature DB >> 34247158

The Impact of Hypo- and Hyperglycemia on Cognition and Brain Development in Young Children with Type 1 Diabetes.

Michal Nevo-Shenker1, Shlomit Shalitin1,2.   

Abstract

Human and experimental animal data suggest both hyperglycemia and hypoglycemia can lead to altered brain structure and neurocognitive function in type 1 diabetes (T1D). Young children with T1D are prone to extreme fluctuations in glucose levels. The overlap of these potential dysglycemic insults to the brain during the time of most active brain and cognitive development may cause cellular and structural injuries that appear to persist into adult life. Brain structure and cognition in persons with T1D are influenced by age of onset, exposure to glycemic extremes such as severe hypoglycemic episodes, history of diabetic ketoacidosis, persistent hyperglycemia, and glucose variability. Studies using brain imaging techniques have shown brain changes that appear to be influenced by metabolic abnormalities characteristic of diabetes, changes apparent at diagnosis and persistent throughout adulthood. Some evidence suggests that brain injury might also directly contribute to psychological and mental health outcomes. Neurocognitive deficits manifest across multiple cognitive domains. Moreover, impaired executive function and mental health can affect patients' adherence to treatment. This review summarizes the current data on the impact of glycemic extremes on brain structure and cognitive function in youth with T1D and the use of new diabetes technologies that may reduce these complications.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Brain function; Diabetes technology; Hyperglycemia; Hypoglycemia; Type 1 diabetes

Mesh:

Year:  2021        PMID: 34247158     DOI: 10.1159/000517352

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  3 in total

1.  Metabolism and memory: α-synuclein level in children with obesity and children with type 1 diabetes; relation to glucotoxicity, lipotoxicity and executive functions.

Authors:  Nouran Yousef Salah; Sara Ibrahim Taha; Safeya Hassan; Mai Seif ElDin Abdeen; Mostafa Ahmad Hashim; Rana Mahmoud
Journal:  Int J Obes (Lond)       Date:  2022-09-24       Impact factor: 5.551

Review 2.  Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review.

Authors:  Chen-Yang Jin; Shi-Wen Yu; Jun-Ting Yin; Xiao-Ying Yuan; Xu-Gang Wang
Journal:  Heliyon       Date:  2022-08-03

Review 3.  Metabolic Treatment of Wolfram Syndrome.

Authors:  Dario Iafusco; Angela Zanfardino; Alessia Piscopo; Stefano Curto; Alda Troncone; Antonietta Chianese; Assunta Serena Rollato; Veronica Testa; Fernanda Iafusco; Giovanna Maione; Alessandro Pennarella; Lucia Boccabella; Gulsum Ozen; Pier Luigi Palma; Cristina Mazzaccara; Nadia Tinto; Emanuele Miraglia Del Giudice
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.